全文获取类型
收费全文 | 1769篇 |
免费 | 76篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 46篇 |
妇产科学 | 54篇 |
基础医学 | 277篇 |
口腔科学 | 35篇 |
临床医学 | 160篇 |
内科学 | 200篇 |
皮肤病学 | 46篇 |
神经病学 | 259篇 |
特种医学 | 151篇 |
外科学 | 184篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 126篇 |
眼科学 | 39篇 |
药学 | 157篇 |
中国医学 | 4篇 |
肿瘤学 | 96篇 |
出版年
2024年 | 2篇 |
2023年 | 8篇 |
2022年 | 25篇 |
2021年 | 45篇 |
2020年 | 20篇 |
2019年 | 34篇 |
2018年 | 51篇 |
2017年 | 36篇 |
2016年 | 46篇 |
2015年 | 56篇 |
2014年 | 62篇 |
2013年 | 110篇 |
2012年 | 158篇 |
2011年 | 188篇 |
2010年 | 116篇 |
2009年 | 63篇 |
2008年 | 138篇 |
2007年 | 146篇 |
2006年 | 138篇 |
2005年 | 114篇 |
2004年 | 94篇 |
2003年 | 76篇 |
2002年 | 52篇 |
2001年 | 5篇 |
2000年 | 3篇 |
1999年 | 6篇 |
1998年 | 4篇 |
1997年 | 10篇 |
1996年 | 4篇 |
1995年 | 7篇 |
1994年 | 6篇 |
1993年 | 4篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 1篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 4篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1971年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有1859条查询结果,搜索用时 0 毫秒
11.
Stanojević NB Ivanović ZJ Djurovic S Kalimanovska VS Spasić S Ostrić DK Memon L 《International heart journal》2005,46(4):593-600
High plasma HDL-cholesterol (HDL-c) is a well-established protective factor in coronary artery disease (CAD). One of its potential protective mechanisms is the inhibition of the cytokine-induced upregulation of expression of cellular adhesion molecules (CAMs). High sCAM levels were found to be associated with low HDL-c in some studies performed mostly in hyperlipidemic subjects, but this association has not yet been investigated in CAD patients. In addition, conflicting results were obtained from in vitro studies that explored the proposed HDL effect on cytokine-induced CAM expression. The aim of the present case-control study was to investigate whether low HDL-c values are associated with CAM overexpression in normolipidemic CAD patients and healthy individuals, matched according to age and gender. Plasma HDL-c, sICAM-1, sVCAM-1, and sE-selectin were measured in 37 normolipidemic patients with angiographically verified coronary artery disease and in 52 healthy normolipidemic subjects. The sCAM values obtained in the subjects (patients or controls) with low HDL-c levels (< 1.03 mmol/L) were compared with the values in the subjects with high HDL-c (>or= 1.03 mmol/L). No significant difference was found between sICAM-1, sVCAM-1, and E-selectin values obtained in subjects with low and high HDL-c, either among the patients or the healthy controls. In conclusion, low HDL-c levels are not associated with CAM overexpression in normolipidemic CAD patients and healthy subjects. 相似文献
12.
13.
Maria Argos Lin Chen Farzana Jasmine Lin Tong Brandon L. Pierce Shantanu Roy Rachelle Paul-Brutus Mary V. Gamble Kristin N. Harper Faruque Parvez Mahfuzar Rahman Muhammad Rakibuz-Zaman Vesna Slavkovich John A. Baron Joseph H. Graziano Muhammad G. Kibriya Habibul Ahsan 《Environmental health perspectives》2015,123(1):64-71
Background: Inorganic arsenic is one of the most common naturally occurring contaminants found in the environment. Arsenic is associated with a number of health outcomes, with epigenetic modification suggested as a potential mechanism of toxicity.Objective: Among a sample of 400 adult participants, we evaluated the association between arsenic exposure, as measured by blood and urinary total arsenic concentrations, and epigenome-wide white blood cell DNA methylation.Methods: We used linear regression models to examine the associations between arsenic exposure and methylation at each CpG site, adjusted for sex, age, and batch. Differentially methylated loci were subsequently examined in relation to corresponding gene expression for functional evidence of gene regulation.Results: In adjusted analyses, we observed four differentially methylated CpG sites with urinary total arsenic concentration and three differentially methylated CpG sites with blood arsenic concentration, based on the Bonferroni-corrected significance threshold of p < 1 × 10–7. Methylation of PLA2G2C (probe cg04605617) was the most significantly associated locus in relation to both urinary (p = 3.40 × 10–11) and blood arsenic concentrations (p = 1.48 × 10–11). Three additional novel methylation loci—SQSTM1 (cg01225779), SLC4A4 (cg06121226), and IGH (cg13651690)—were also significantly associated with arsenic exposure. Further, there was evidence of methylation-related gene regulation based on gene expression for a subset of differentially methylated loci.Conclusions: We observed significant associations between arsenic exposure and gene-specific differential white blood cell DNA methylation, suggesting that epigenetic modifications may be an important pathway underlying arsenic toxicity. The specific differentially methylated loci identified may inform potential pathways for future interventions.Citation: Argos M, Chen L, Jasmine F, Tong L, Pierce BL, Roy S, Paul-Brutus R, Gamble MV, Harper KN, Parvez F, Rahman M, Rakibuz-Zaman M, Slavkovich V, Baron JA, Graziano JH, Kibriya MG, Ahsan H. 2015. Gene-specific differential DNA methylation and chronic arsenic exposure in an epigenome-wide association study of adults in Bangladesh. Environ Health Perspect 123:64–71; http://dx.doi.org/10.1289/ehp.1307884 相似文献
14.
15.
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients 总被引:1,自引:0,他引:1
Marusic M Babic Z Nesanovic M Lucijanic-Mlinac M Stajcar V 《World journal of gastroenterology : WJG》2005,11(15):2334-2336
AM: Intestinal metaplasia (IM) is more often found in patients with Helicobacterpylori(Hpylori) infection, while eradication of H pylori results in significant reduction in the severity and activity of chronic gastritis. We aimed to determine in patients with unsuccessful eradication of Hpylori the role of various proton pump inhibitors (PPIs) having different mechanisms in the resolution of IM. METHODS: We confirmed endoscopically and pathohistologically (Sydney classification) the IM in 335 patients with gastritis before and after medication for eradication of H pylori (Maastricht Protocol 2002). H pylori infection was determined by using histology, urease test and culture. Control endoscopy and histology were done after 30 d and thereafter (within 1 year). Unsuccessful eradication was considered if only one of the three tests (histology, urease and culture) was negative after therapy protocol. We used omeprazole, pantoprazole, lansoprazole in therapy protocols (in combination with two antibiotics). RESULTS: We found no significant difference in resolution of IM by using different PPI between the groups of eradicated and noneradicated patients (P<0.4821 and P<0.4388, respectively). CONCLUSION: There is no significant difference in resolution of intestinal metaplasia by different proton pump inhibitors. 相似文献
16.
Connor WJ Bevington Ju-Chieh Cheng Ivan S Klyuzhin Mariya V Cherkasova Catharine A Winstanley Vesna Sossi 《Journal of cerebral blood flow and metabolism》2021,41(1):116
Current methods using a single PET scan to detect voxel-level transient dopamine release—using F-test (significance) and cluster size thresholding—have limited detection sensitivity for clusters of release small in size and/or having low release levels. Specifically, simulations show that voxels with release near the peripheries of such clusters are often rejected—becoming false negatives and ultimately distorting the F-distribution of rejected voxels. We suggest a Monte Carlo method that incorporates these two observations into a cost function, allowing erroneously rejected voxels to be accepted under specified criteria. In simulations, the proposed method improves detection sensitivity by up to 50% while preserving the cluster size threshold, or up to 180% when optimizing for sensitivity. A further parametric-based voxelwise thresholding is then suggested to better estimate the release dynamics in detected clusters. We apply the Monte Carlo method to a pilot scan from a human gambling study, where additional parametrically unique clusters are detected as compared to the current best methods—results consistent with our simulations. 相似文献
17.
Maria Malm Kirsi Tamminen Suvi Lappalainen Hanni Uusi-Kerttula Timo Vesikari Vesna Blazevic 《Clinical and Vaccine Immunology : CVI》2015,22(6):656-663
Norovirus (NoV) genogroup I (GI) and GII are responsible for most human infections with NoV. Because of the high genetic variability of NoV, natural infection does not induce sufficient protective immunity to different genotypes or to variants of the same genotype and there is little or no cross-protection against different genogroups. NoV-derived virus-like particles (VLPs) are promising vaccine candidates that induce high levels of NoV-specific humoral and cellular immune responses. It is believed that a bivalent NoV vaccine consisting of a representative VLP from GI and GII is a minimum requirement for an effective vaccine. Here, we compared the abilities of monovalent immunizations with NoV GI.1-2001, GI.3-2002, GII.4-1999, and GII.4-2010 New Orleans VLPs to induce NoV type-specific and cross-reactive immune responses and protective blocking antibody responses in BALB/c mice. All of the VLPs induced comparable levels of type-specific serum IgG antibodies, as well as blocking antibodies to the VLPs used for immunization. However, the abilities of different VLP genotypes to induce cross-reactive IgG and cross-blocking antibodies varied remarkably. Our results confirm previous findings of a lack of cross-protective immune responses between GI and GII NoVs. These data support the rationale for including NoV GI.3 and GII.4-1999 VLPs in the bivalent vaccine formulation, which could be sufficient to induce protective immune responses across NoV genotypes in the two common genogroups in humans. 相似文献
18.
19.
20.